IBT Publications by Zitron

Journal Articles (4)

E. P. Scholz, P. Carrillo-Bustamante, F. Fischer, M. Wilhelms, E. Zitron, O. Dössel, H. A. Katus, and G. Seemann.
Rotor termination is critically dependent on kinetic properties of I kur inhibitors in an in silico model of chronic atrial fibrillation.
In PloS one, vol. 8(12) , pp. e83179, 2013
D. Scherer, D. Hassel, R. Bloehs, E. Zitron, K. von Lowenstern, C. Seyler, D. Thomas, F. Konrad, H. F. Burgers, G. Seemann, W. Rottbauer, H. A. Katus, C. A. Karle, and E. P. Scholz.
Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents.
In British Journal of Pharmacology, vol. 156(2) , pp. 226-236, 2009
D. Hassel, E. P. Scholz, N. Trano, O. Friedrich, S. Just, B. Meder, D. L. Weiss, E. Zitron, S. Marquardt, C. A. Karle, G. Seemann, M. C. Fishman, H. A. Katus, and W. Rottbauer.
Deficient zebrafish ether-a-go-go-related gene channel gating causes short-QT syndrome in zebrafish reggae mutants.
In Circulation, vol. 117(7) , pp. 866--875, 2008
E. P. Scholz, F. M. Konrad, D. L. Weiss, E. Zitron, C. Kiesecker, R. Bloehs, M. Kulzer, D. Thomas, S. Kathöfer, A. Bauer, M. H. Maurer, G. Seemann, H. A. Katus, and C. A. Karle.
Anticholinergic antiparkinson drug orphenadrine inhibits HERG channels: block attenuation by mutations of the pore residues Y652 or F656.
In Naunyn-Schmiedebergís Arch. Pharmacol., vol. 376(4) , pp. 275-284, 2007